Andere talen Kidswell Bio Corporation

Aandelen

4584

JP3386460004

Vertraagde tijd Japan Exchange Andere beurzen 05:50:33 07-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
139 ^JPY	+2,21%		+0,72%	+3,73%

2022	Japanse index vlakt winst af door inflatiedruk; Dena neemt meerderheidsbelang in mobiele ICT-activiteiten voor $ 230 miljoen	MT
2021	Kidswell Bio Corporation maakt winstcijfers bekend voor het halfjaar dat eindigde op 30 september 2021	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Kidswell Bio Corporation announced that it has received ¥22.8 million in funding from CVI Investments, Inc.	26-07-23
Kidswell Bio Corporation announced that it expects to receive Â¥22.8 million in funding from CVI Investments, Inc.	10-07-23
Kidswell Bio Corporation(TSE:4584) dropped from S&P Global BMI Index	19-09-22
Japan Index Trims Gains over Inflationary Pressures; Dena to Take Majority Stake in Mobile ICT Business for $230 Million	27-05-22
Chiome Bioscience, Kidswell Bio to Collaborate on Development of Cancer Antibody	27-05-22
Kidswell Bio Corporation Reports Earnings Results for the Half Year Ended September 30, 2021	05-11-21
Kidswell Bio Corporation(TSE:4584) added to S&P Global BMI Index	20-09-21
Gene Techno Science : Announcement of Joint Research Agreement with Hokkaido University and Spinal Injuries Center for Non-Union Fractures	21-08-20
Gene Techno Science Co.,Ltd. Reports Earnings Results for the Year Ended March 2020	17-07-20
Dojin Group Co., Ltd. entered into a share transfer agreement to acquire Advanced Cell Technology and Engineering Ltd. from Gene Techno Science Co.,Ltd. for ¥0.	10-07-20
Gene Techno Science : Announcement of completion of issuance of the 3rd series of convertible bond with stock acquisition rights	09-04-20
Gene Techno Science Co.,Ltd. announced that it has received ¥604.852632 million in funding from CVI Investments, Inc.	08-04-20
Gene Techno Science Co.,Ltd. announced that it expects to receive ¥604.852632 million in funding from CVI Investments, Inc.	23-03-20
Gene Techno Science Enters into Research Agreement with Nagoya University	07-03-20
Gene Techno Science Co., Ltd Has Executes A Joint Research Agreement with Oita University	07-03-20
Gene Techno Science Co.,Ltd. acquired remaining 94.7% stake in Japan Regenerative Medicine Co., Ltd. from Noritsu Koki Co., Ltd. for ¥0.	17-02-20
Gene Techno Science : Signed alliance agreement with Eil for business development in regenerative medicine and healthcare area	31-01-20
Gene Techno Science : Announcement of Joint Research Agreement for New Antibodies with MabGenesis Inc.	22-01-20
Gene Techno Science : Announcement of Joint Development Agreement of Aflibercept Biosimilars with Kishi Kasei Co., Ltd.	02-12-19
Gene Techno Science Co.,Ltd. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2020	05-11-19

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Kidswell Bio Corporation

Aandelen

4584

JP3386460004

Andere talen

Filters